ESM1 and neoplasm: The non-glycanated mouse or human endocan polypeptide (previously known as endothelial cell specific molecule-1, ESM-1) restrains tumor growth by increasing leukocyte infiltration in vivo and enhancing innate immunity response (Yassine et al., 2015).